SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹9.56 Cr | ₹13 Cr | ₹11 Cr | ₹8.14 Cr | ₹1.01 Cr |
What is the latest Total Non-Current Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹9.56 Cr |
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹8.14 Cr |
| Mar2022 | ₹1.01 Cr |
How is Total Non-Current Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹9.56 Cr | -26.77 | |
| Mar2025 | ₹13 Cr | 20.42 | |
| Mar2024 | ₹11 Cr | 33.16 | |
| Mar2023 | ₹8.14 Cr | 709.34 | |
| Mar2022 | ₹1.01 Cr | - | |
Compare Total Non-Current Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹135.2 Cr | -4.7% | 21.7% | -26.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -4.7% |
21.7% |
-26.5% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses